Search Within

Robin Guo

  1. "Early Drug Development Service"
Formats
  1. Journal Article (2)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (4)
  2. Early Drug Development Service (4)
  3. GDMT, Medicine (4)
  4. Gynecologic Medicine Service (4)
  5. Gynecology Disease Management Team (4)
  6. Solid Tumor Oncology Division (4)

More Groups

People
  1. Alexander Drilon (2)
  2. Alison Schram (2)
  3. David Hyman (2)
  4. Ezra Rosen (2)
  5. Alexia Iasonos (1)
  6. Aliya Holland (1)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2020 (1)
  4. 2019 (1)
Publications
  1. Annals of Oncology (1)
  2. International Journal of Radiation Oncology, Biology, Physics (1)
  3. JCO Precision Oncology (1)
  4. Journal of Clinical Oncology (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. Elsevier Inc. (1)
  3. Oxford University Press (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genotypically-selected pan cancer trial of camonsertib with palliative radiation in the treatment of metastatic tumors harboring an ataxia-telangiectasia mutated (ATM) mutation
    Meeting Abstract

    Lee, N. Y.; Michelle, R.; Huang, M.; Guo, R.; Ferreira, V.; Merril, M.; Sgroe, E.; Unger, T.; Koehler, M.; Setton, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Characterization of on-target adverse events caused by TRK inhibitor therapy
    Journal Article

    Liu, D.; Flory, J.; Lin, A.; Offin, M.; Falcon, C. J.; Murciano-Goroff, Y. R.; Rosen, E.; Guo, R.; Basu, E.; Li, B. T.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Response to selective RET inhibition with LOXO-292 in a patient with RET fusion-positive lung cancer with leptomeningeal metastases
    Journal Article

    Guo, R.; Schreyer, M.; Chang, J. C.; Rothenberg, S. M.; Henry, D.; Cotzia, P.; Kris, M. G.; Rekhtman, N.; Young, R. J.; Hyman, D. M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save